Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(35)
•••
Comment by Gustoeson Jan 09, 2015 11:02am
102 Views
Post# 23302045

RE:RE:RE:RE:Preclinical Work at U of T and Princess Margaret

RE:RE:RE:RE:Preclinical Work at U of T and Princess Margaret
Macer wrote: Thera20
I could only offer you an educated guess on how long it would take to run the optimization studies.
I am assuming that with your OCD you will want it nailed down to the exact date and time and thus I cannot entertain your ask. Knowing you are already not happy with the timelines I would suggest that you take the next opportunity to get out of your position.

Question for the board to generate discussion.

Scenario, you have two choices. 1. Sell all of you position in TLT today for $1.00 per share and never be allowed to trade or invest in TLT ever again. OR 2. Remain with your shares indefenitely and hopefully until it is much greater than $1.00

How many would sell today for $1.00

Macer


In Scenario #1, IF I was not allowed to trade/invest in TLT again after selling, I would not sell at $1, not a chance.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities